Leaflet NODRIGA 50mg film-coated tablets
Indicated for: chronic myeloid leukemia
Route of administration: oral
Substance: dasatinib (tyrosine kinase inhibitor)
ATC: L01EA02 (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors)
This medicine may affect fertility.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
Avoid grapefruit and grapefruit juice.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
This medicine may increase the risk of heart rhythm disturbances.
Dasatinib is a medication used for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome positivity. It acts as a tyrosine kinase inhibitor, blocking signals that promote cancer cell growth.
The medication is taken orally, usually once daily, and is effective in reducing the number of leukemic cells and prolonging patient survival. It is used in both chronic and advanced phases of the disease.
Side effects may include fluid retention, nausea, diarrhea, fatigue, and muscle pain. In rare cases, severe complications such as pulmonary hypertension or bone marrow suppression may occur. Regular monitoring is essential.
Consult your doctor to discuss the benefits and risks of treatment with Dasatinib. Follow the prescribed dosage and adhere to all medical recommendations.
General data about NODRIGA 50mg
- Substance: dasatinib
- Date of last drug list: 01-06-2026
- Commercial code: W69073002
- Concentration: 50mg
- Pharmaceutical form: film-coated tablets
- Quantity: 60
- Product type: generic
- Price: 4658.67 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for dasatinib
- 100mg
- 111mg
- 140mg
- 16mg
- 20mg
- 40mg
- 50mg
- 55mg
- 63mg
- 70mg
- 79mg
- 80mg